These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

839 related articles for article (PubMed ID: 14693513)

  • 1. Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae.
    Poirel L; Héritier C; Tolün V; Nordmann P
    Antimicrob Agents Chemother; 2004 Jan; 48(1):15-22. PubMed ID: 14693513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae.
    Yigit H; Queenan AM; Anderson GJ; Domenech-Sanchez A; Biddle JW; Steward CD; Alberti S; Bush K; Tenover FC
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1151-61. PubMed ID: 11257029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imipenem resistance in Klebsiella pneumoniae is associated to the combination of plasmid-mediated CMY-4 AmpC β-lactamase and loss of an outer membrane protein.
    Dahmen S; Mansour W; Charfi K; Boujaafar N; Arlet G; Bouallègue O
    Microb Drug Resist; 2012 Oct; 18(5):479-83. PubMed ID: 22690752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbapenem-resistant strain of Klebsiella oxytoca harboring carbapenem-hydrolyzing beta-lactamase KPC-2.
    Yigit H; Queenan AM; Rasheed JK; Biddle JW; Domenech-Sanchez A; Alberti S; Bush K; Tenover FC
    Antimicrob Agents Chemother; 2003 Dec; 47(12):3881-9. PubMed ID: 14638498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and the foss of an outer membrane protein.
    Bradford PA; Urban C; Mariano N; Projan SJ; Rahal JJ; Bush K
    Antimicrob Agents Chemother; 1997 Mar; 41(3):563-9. PubMed ID: 9055993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emergence of imipenem resistance in Klebsiella pneumoniae owing to combination of plasmid-mediated CMY-4 and permeability alteration.
    Cao VT; Arlet G; Ericsson BM; Tammelin A; Courvalin P; Lambert T
    J Antimicrob Chemother; 2000 Dec; 46(6):895-900. PubMed ID: 11102406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and mechanisms of decreased susceptibility to carbapenems in Klebsiella pneumoniae isolates.
    Kim SY; Park YJ; Yu JK; Kim HS; Park YS; Yoon JB; Yoo JY; Lee K
    Diagn Microbiol Infect Dis; 2007 Jan; 57(1):85-91. PubMed ID: 16854555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OXA-162, a novel variant of OXA-48 displays extended hydrolytic activity towards imipenem, meropenem and doripenem.
    Kasap M; Torol S; Kolayli F; Dundar D; Vahaboglu H
    J Enzyme Inhib Med Chem; 2013 Oct; 28(5):990-6. PubMed ID: 22845331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OXA-60, a chromosomal, inducible, and imipenem-hydrolyzing class D beta-lactamase from Ralstonia pickettii.
    Girlich D; Naas T; Nordmann P
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4217-25. PubMed ID: 15504844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical sequence analyses of GES-1, a novel class A extended-spectrum beta-lactamase, and the class 1 integron In52 from Klebsiella pneumoniae.
    Poirel L; Le Thomas I; Naas T; Karim A; Nordmann P
    Antimicrob Agents Chemother; 2000 Mar; 44(3):622-32. PubMed ID: 10681329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the extended-spectrum beta-lactamase reference strain, Klebsiella pneumoniae K6 (ATCC 700603), which produces the novel enzyme SHV-18.
    Rasheed JK; Anderson GJ; Yigit H; Queenan AM; Doménech-Sánchez A; Swenson JM; Biddle JW; Ferraro MJ; Jacoby GA; Tenover FC
    Antimicrob Agents Chemother; 2000 Sep; 44(9):2382-8. PubMed ID: 10952583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sources of diversity of carbapenem resistance levels in Klebsiella pneumoniae carrying blaVIM-1.
    Loli A; Tzouvelekis LS; Tzelepi E; Carattoli A; Vatopoulos AC; Tassios PT; Miriagou V
    J Antimicrob Chemother; 2006 Sep; 58(3):669-72. PubMed ID: 16870645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-level expression of chromosomally encoded SHV-1 beta-lactamase and an outer membrane protein change confer resistance to ceftazidime and piperacillin-tazobactam in a clinical isolate of Klebsiella pneumoniae.
    Rice LB; Carias LL; Hujer AM; Bonafede M; Hutton R; Hoyen C; Bonomo RA
    Antimicrob Agents Chemother; 2000 Feb; 44(2):362-7. PubMed ID: 10639363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of β-lactamase genes among carbapenem-resistant Klebsiella pneumoniae strains isolated from patients in Turkey.
    Iraz M; Özad Düzgün A; Sandallı C; Doymaz MZ; Akkoyunlu Y; Saral A; Peleg AY; Özgümüş OB; Beriş FŞ; Karaoğlu H; Çopur Çiçek A
    Ann Lab Med; 2015 Nov; 35(6):595-601. PubMed ID: 26354347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and contributing factors of nonsusceptibility to imipenem or meropenem in extended-spectrum β-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
    Park YJ; Yu JK; Park KG; Park YG; Lee S; Kim SY; Jeong SH
    Diagn Microbiol Infect Dis; 2011 Sep; 71(1):87-9. PubMed ID: 21397426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Collateral damage of flomoxef therapy: in vivo development of porin deficiency and acquisition of blaDHA-1 leading to ertapenem resistance in a clinical isolate of Klebsiella pneumoniae producing CTX-M-3 and SHV-5 beta-lactamases.
    Lee CH; Chu C; Liu JW; Chen YS; Chiu CJ; Su LH
    J Antimicrob Chemother; 2007 Aug; 60(2):410-3. PubMed ID: 17576696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Underlying mechanisms of carbapenem resistance in extended-spectrum β-lactamase-producing Klebsiella pneumoniae and Escherichia coli isolates at a tertiary care centre in Lebanon: role of OXA-48 and NDM-1 carbapenemases.
    Baroud M; Dandache I; Araj GF; Wakim R; Kanj S; Kanafani Z; Khairallah M; Sabra A; Shehab M; Dbaibo G; Matar GM
    Int J Antimicrob Agents; 2013 Jan; 41(1):75-9. PubMed ID: 23142087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GES-2, a class A beta-lactamase from Pseudomonas aeruginosa with increased hydrolysis of imipenem.
    Poirel L; Weldhagen GF; Naas T; De Champs C; Dove MG; Nordmann P
    Antimicrob Agents Chemother; 2001 Sep; 45(9):2598-603. PubMed ID: 11502535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic and Biochemical Characterization of OXA-519, a Novel OXA-48-Like β-Lactamase.
    Dabos L; Bogaerts P; Bonnin RA; Zavala A; Sacré P; Iorga BI; Huang DT; Glupczynski Y; Naas T
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29866857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced ceftazidime and ertapenem susceptibility due to production of OXA-2 in Klebsiella pneumoniae ST258.
    Iovleva A; Mettus RT; McElheny CL; Mustapha MM; Van Tyne D; Shields RK; Pasculle AW; Cooper VS; Doi Y
    J Antimicrob Chemother; 2019 Aug; 74(8):2203-2208. PubMed ID: 31127290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.